Rocket Lab (RKLB) Q3 2025 Financial Results Summary
QuoteReporter
•5 min read
Rocket Lab Corporation (RKLB) Q3 2025 Financial Results Summary
Rocket Lab Corporation (Nasdaq: RKLB) announced its third quarter financial results for the fiscal year ended September 30, 2025, on November 10, 2025. The company reported significant growth in revenue and gross margins compared to the same quarter a year ago, highlighting its success in the launch services market.
Financial Highlights for Q3 2025
- Total Revenue: $155.1 million, a 48% increase compared to $104.8 million in Q3 2024.
- GAAP Gross Profit: $57.3 million, up from $28.0 million in Q3 2024, indicating a growth rate of 104%.
- GAAP Gross Margin: 37% compared to 27% in Q3 2024, representing a substantial increase in profitability.
- Operating Loss: $59.0 million, compared to an operating loss of $51.9 million in the same period last year.
- Net Loss: $18.3 million, a decrease from a loss of $51.9 million in Q3 2024.
- Net Loss per Share: $0.03, compared to $0.10 in Q3 2024.
Revenues Breakdown
- Product Revenues: $104.0 million, an increase of 31% from $79.4 million in Q3 2024.
- Service Revenues: $51.0 million, a 101% increase over $25.4 million in Q3 2024.
Expense Highlights
- Total Operating Expenses: Increased to $116.3 million from $79.9 million in Q3 2024.
- Research and Development Expenses: $70.7 million, compared to $47.7 million in Q3 2024, up 48%.
- Selling, General and Administrative Expenses: $45.6 million, increasing from $32.2 million in Q3 2024, reflecting a 42% growth.
Cash Flow and Liquidity
- Net Cash Used in Operating Activities: $101.0 million, compared to $46.5 million for the same period in 2024.
- The company reported ending cash and cash equivalents of $807.9 million, showing a significant increase from $271.0 million as of December 31, 2024.
Shareholder Actions
- Rocket Lab has not declared any quarterly dividends for this period.
- The company completed an at-the-market offering, leading to an increase in liquidity to over $1 billion, enhancing its capacity for future acquisitions and initiatives.
Acquisition and Strategic Developments
- Rocket Lab secured 17 Electron launch contracts in Q3 2025, contributing to a record backlog and indicating strong demand for its services.
- Successful launches of two back-to-back HASTE missions demonstrated rapid delivery capabilities and support for advancements in hypersonic technology.
- The company completed the acquisition of Geost for up to $325 million to enhance its capabilities in payload systems for U.S. national security.
- The opening of Launch Complex 3 and the progress of the Neutron rocket’s development position Rocket Lab for significant growth.
Fourth Quarter 2025 Guidance
For the fourth quarter of 2025, Rocket Lab expects:
– Revenue: Between $170 million and $180 million.
– GAAP Gross Margins: Expected between 37% and 39%.
– Non-GAAP Operating Expenses: Between $107 million and $113 million.
– Adjusted EBITDA Loss: Anticipated between $23 million and $29 million.
In summary, Rocket Lab’s Q3 2025 results reflect strong operational growth, driven by increased revenue, improved gross margins, and ongoing strategic initiatives, setting the stage for future expansion in the aerospace sector.
| Revenues: | Three Months Ended | Nine Months Ended | ||
|---|---|---|---|---|
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | |
| Product revenues | 104,042 | 79,419 | 277,571 | 205,848 |
| Service revenues | 51,038 | 25,389 | 144,576 | 97,978 |
| Total revenues | 155,080 | 104,808 | 422,147 | 303,826 |
| Cost of revenues: | ||||
| Cost of product revenues | 72,841 | 58,448 | 188,402 | 153,215 |
| Cost of service revenues | 24,925 | 18,364 | 94,796 | 71,279 |
| Total cost of revenues | 97,766 | 76,812 | 283,198 | 224,494 |
| Gross profit | 57,314 | 27,996 | 138,949 | 79,332 |
| Operating expenses: | ||||
| Research and development, net | 70,694 | 47,723 | 191,937 | 126,139 |
| Selling, general and administrative | 45,589 | 32,172 | 124,808 | 91,445 |
| Total operating expenses | 116,283 | 79,895 | 316,745 | 217,584 |
| Operating loss | -58,969 | -51,899 | -177,796 | -138,252 |
| Other income (expense): | ||||
| Interest expense, net | -590 | -454 | -5,547 | -2,176 |
| Gain (loss) on foreign exchange | 388 | -490 | -235 | -465 |
| Other (expense) income, net | -177 | 1,848 | -675 | 3,152 |
| Total other (expense) income, net | -379 | 904 | -6,457 | 511 |
| Loss before income taxes | -59,348 | -50,995 | -184,253 | -137,741 |
| Benefit (provision) for income taxes | 41,091 | -944 | 38,966 | -89 |
| Net loss | -18,257 | -51,939 | -145,287 | -137,830 |
| Net loss per share attributable to Rocket Lab Corporation: | ||||
| Basic and diluted | -0.03 | -0.10 | -0.28 | -0.28 |
| Weighted-average common shares outstanding | 528,725,980 | 497,701,715 | 516,560,266 | 493,976,025 |
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 807,875 | 271,042 |
| Marketable securities, current | 168,865 | 147,948 |
| Accounts receivable, net | 59,086 | 36,440 |
| Contract assets | 52,785 | 63,108 |
| Inventories | 144,999 | 119,074 |
| Prepaids and other current assets | 82,813 | 55,009 |
| Total current assets | 1,316,423 | 692,621 |
| Non-current assets: | ||
| Property, plant and equipment, net | 278,003 | 194,838 |
| Intangible assets, net | 231,984 | 58,637 |
| Goodwill | 217,709 | 71,020 |
| Right-of-use assets – operating leases | 90,844 | 53,664 |
| Right-of-use assets – finance leases | 14,022 | 14,396 |
| Marketable securities, non-current | 46,202 | 60,686 |
| Restricted cash | 4,835 | 4,260 |
| Deferred income tax assets, net | — | 3,010 |
| Other non-current assets | 21,373 | 31,210 |
| Total assets | 2,221,395 | 1,184,342 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Trade payables | 61,229 | 53,059 |
| Accrued expenses | 17,961 | 19,460 |
| Employee benefits payable | 82,174 | 20,847 |
| Contract liabilities | 208,243 | 216,160 |
| Current installments of long-term borrowings | 17,090 | 12,045 |
| Other current liabilities | 27,760 | 17,954 |
| Total current liabilities | 414,457 | 339,525 |
| Non-current liabilities: | ||
| Convertible senior notes, net | 347,014 | 345,392 |
| Long-term borrowings, net, excluding current installments | 51,267 | 44,049 |
| Non-current operating lease liabilities | 86,505 | 51,965 |
| Non-current finance lease liabilities | 14,742 | 14,970 |
| Deferred tax liabilities | 3,007 | 891 |
| Other non-current liabilities | 23,417 | 5,097 |
| Total liabilities | 940,409 | 801,889 |
| COMMITMENTS AND CONTINGENCIES | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: | 5 | — |
| Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 542,175,866 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively; outstanding shares: 496,224,616 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively | 50 | 50 |
| Treasury stock, at cost; shares: 45,951,250 and 0 at September 30, 2025 and December 31, 2024, respectively | — | — |
| Additional paid-in capital | 2,241,982 | 1,198,909 |
| Accumulated deficit | -958,988 | -813,701 |
| Accumulated other comprehensive loss | -2,063 | -2,805 |
| Total stockholders’ equity | 1,280,986 | 382,453 |
| Total liabilities and stockholders’ equity | 2,221,395 | 1,184,342 |